Search research articles
Contact Us
Filters
Showing results (71-80 of 102) with videos related to
Page
of 11
Sort By:
BMJ (Clinical Research Ed.)
|
February 22, 2005
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial
Clive Ballard, Marisa Margallo-Lana, Edmund Juszczak, et al.
Indian Heart Journal
|
October 15, 2022
Development and validation of a mobile application based on a machine learning model to aid in predicting dosage of vitamin K antagonists among Indian patients post mechanical heart valve replacement
M Amruthlal, S Devika, Vignesh Krishnan, et al.
Redox Biology
|
June 2, 2019
HDL subclass proteomic analysis and functional implication of protein dynamic change during HDL maturation
Yuling Zhang, Scott M Gordon, Hang Xi, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 21, 2017
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
John T O'Brien, Clive Holmes, Matthew Jones, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 26, 2022
Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy
Leonidas Chouliaras, Alan Thomas, Maura Malpetti, et al.
Journal of the International Neuropsychological Society : JINS
|
October 20, 2021
Neuropsychological Impairments and Their Cognitive Architecture in Mild Cognitive Impairment (MCI) with Lewy Bodies and MCI-Alzheimer's Disease
Joanna Ciafone, Alan Thomas, Rory Durcan, et al.
Journal of Alzheimer'S Disease : JAD
|
August 12, 2017
PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers
Ivan Koychev, Roger N Gunn, Azadeh Firouzian, et al.
Journal of the American Medical Directors Association
|
December 20, 2014
A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD)
Clive Ballard, Alan Thomas, Stephen Gerry, et al.
Epigenetics
|
August 22, 2024
Genetic architecture of epigenetic cortical clock age in brain tissue from older individuals: alterations in <i>CD46</i> and other loci
Francine Grodstein, Bernardo Lemos, Jingyun Yang, et al.
Nature Genetics
|
December 13, 2006
Genome variation and evolution of the malaria parasite Plasmodium falciparum
Daniel C Jeffares, Arnab Pain, Andrew Berry, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 102) with videos related to
Sort By:
Page
of 11
BMJ (Clinical Research Ed.)
|
February 22, 2005
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial
Clive Ballard, Marisa Margallo-Lana, Edmund Juszczak, et al.
Indian Heart Journal
|
October 15, 2022
Development and validation of a mobile application based on a machine learning model to aid in predicting dosage of vitamin K antagonists among Indian patients post mechanical heart valve replacement
M Amruthlal, S Devika, Vignesh Krishnan, et al.
Redox Biology
|
June 2, 2019
HDL subclass proteomic analysis and functional implication of protein dynamic change during HDL maturation
Yuling Zhang, Scott M Gordon, Hang Xi, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 21, 2017
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
John T O'Brien, Clive Holmes, Matthew Jones, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 26, 2022
Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy
Leonidas Chouliaras, Alan Thomas, Maura Malpetti, et al.
Journal of the International Neuropsychological Society : JINS
|
October 20, 2021
Neuropsychological Impairments and Their Cognitive Architecture in Mild Cognitive Impairment (MCI) with Lewy Bodies and MCI-Alzheimer's Disease
Joanna Ciafone, Alan Thomas, Rory Durcan, et al.
Journal of Alzheimer'S Disease : JAD
|
August 12, 2017
PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers
Ivan Koychev, Roger N Gunn, Azadeh Firouzian, et al.
Journal of the American Medical Directors Association
|
December 20, 2014
A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD)
Clive Ballard, Alan Thomas, Stephen Gerry, et al.
Epigenetics
|
August 22, 2024
Genetic architecture of epigenetic cortical clock age in brain tissue from older individuals: alterations in <i>CD46</i> and other loci
Francine Grodstein, Bernardo Lemos, Jingyun Yang, et al.
Nature Genetics
|
December 13, 2006
Genome variation and evolution of the malaria parasite Plasmodium falciparum
Daniel C Jeffares, Arnab Pain, Andrew Berry, et al.
Page
of 11